Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201608029593N5Phase 3Completed
Phase 3 trial of lidocaine in breast cancer (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Inflammatory prognostic scores. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201608029593N5.